MALIGNANT FORMATION OF THE GALLBLADDER: DESCRIPTION OF A CLINICAL CASE
Main Article Content
Abstract
Gallbladder cancer is the most common biliary epithelial malignancy, characterized by an extremely poor prognosis due to its aggressive course and limited treatment options. This is often associated with late-stage diagnosis. Long-term chronic inflammation is a significant factor in the development of GERD, regardless of its lithiasis or nonlithiasis origin. Early detection at a treatable stage remains challenging, as patients rarely exhibit symptoms. Differential diagnosis of gallbladder malignancy is challenging because symptoms are often nonspecific and mimic other, more common gallbladder and biliary tract diseases. Prognosis depends on the tumor stage, with early detection of the disease being critical for long-term survival.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
1. Roa JC, García P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022; 8(1): 75. doi: 10.1038/s41572-022-00408-z
2. Waller GC, Sarpel U. Gallbladder Cancer. Surg Clin North Am. 2024; 104(6): 1263-1280. doi: 10.1016/j.suc.2024.03.006
3. Marcinak CT, Abbott DE. Gallbladder Cancer. Cancer Treat Res. 2024; 192: 147-163. doi: 10.1007/978-3-031-61238-1_8
4. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014; 6: 99-109. doi: 10.2147/CLEP.S37357
5. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014; 6: 99-109. doi: 10.2147/CLEP.S37357
6. Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma – evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018; 15(2): 95-111. doi: 10.1038/nrclinonc.2017.157
7. Baiu I, Visser B. Gallbladder Cancer. JAMA. 2018; 320(12): 1294. doi: 10.1001/jama.2018.11815
8. Benson AB, D'Angelica MI, Abbott DE, Anaya DA, Anders R, Are C, et al. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021; 19(5): 541-565. doi: 10.6004/jnccn.2021.0022
9. Roa JC, García P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022; 8(1): 69. doi: 10.1038/s41572-022-00398-y
10. Vogel A, Bridgewater J, Edeline J, Kelley RK, Klümpen HJ, Malka D, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023; 34(2): 127-140. doi: 10.1016/j.annonc.2022.10.506